Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial
Magnus Holmer, Catarina Lindqvist, Sven Petersson, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100256-100256
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 642
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 281
Lifestyle interventions in nonalcoholic fatty liver disease
Zobair M. Younossi, Shira Zelber‐Sagi, Linda Henry, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 11, pp. 708-722
Closed Access | Times Cited: 128
Diet and exercise in NAFLD/NASH: Beyond the obvious
Georg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2249-2268
Open Access | Times Cited: 118
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis
Laura Haigh, Colette Kirk, Khalil El Gendy, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 9, pp. 1913-1931
Open Access | Times Cited: 117
Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial
Mark Ezpeleta, Kelsey Gabel, Sofia Cienfuegos, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 56-70.e3
Open Access | Times Cited: 93
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 54
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1
Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1371-1393.e7
Open Access | Times Cited: 25
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus
Xufen Zeng, Krista A Varady, Xiangdong Wang, et al.
Metabolism (2024) Vol. 161, pp. 156028-156028
Closed Access | Times Cited: 20
Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
Angelo Armandi, Elisabetta Bugianesi
European Journal of Internal Medicine (2024) Vol. 122, pp. 20-27
Closed Access | Times Cited: 18
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 3
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Paweł Rajewski, Jakub Cieściński, Piotr Rajewski, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 217-217
Open Access | Times Cited: 2
Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
Sakkarin Chirapongsathorn, Wiwit Rintaravitoon, Bhagawat Tangjaturonrasme, et al.
JGH Open (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025) Vol. 14, pp. 100164-100164
Open Access | Times Cited: 2
Current Options and Future Directions for NAFLD and NASH Treatment
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7571-7571
Open Access | Times Cited: 74
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Camilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
Annals of Internal Medicine (2022) Vol. 176, Iss. 1, pp. 10-21
Closed Access | Times Cited: 64
Effects of Dietary α-Linolenic Acid Treatment and the Efficiency of Its Conversion to Eicosapentaenoic and Docosahexaenoic Acids in Obesity and Related Diseases
Marija Takić, Biljana Pokimica, Gordana Petrović-Oggiano, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4471-4471
Open Access | Times Cited: 52
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
Raja Gopal Reddy Mooli, Sadeesh K. Ramakrishnan
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 51
Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
Hamed Kord‐Varkaneh, Ammar Salehi sahlabadi, Mihnea‐Alexandru Găman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 43
NAFLD and thyroid function: pathophysiological and therapeutic considerations
Erifili Hatziagelaki, Stavroula Α. Paschou, Martin Schön, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 755-768
Open Access | Times Cited: 43
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
Thomas Marjot, Jeremy Tomlinson, Leanne Hodson, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1607-1619
Open Access | Times Cited: 38
Fasting: From Physiology to Pathology
Dongmei Tang, Qiuyan Tang, Wei Huang, et al.
Advanced Science (2023) Vol. 10, Iss. 9
Open Access | Times Cited: 37
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Fernando Bril, Arun J. Sanyal, Kenneth Cusi
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 187-210
Closed Access | Times Cited: 34
Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis
Xiao-Ni Chai, Bingqian Zhou, Ning Ni, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 29
Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis
Marcia Lange, Devika Nadkarni, Lily Martin, et al.
Hepatology Communications (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top